COMPANIES The takeover battle for Goldshield, the drugs company, took another twist Sunday night after a management buy-out team sweetened its cash offer to 485p a share and moved to shut out a rival bid by the Fuhrer family, owners of one of Israel’s leading pharmaceutical businesses.
Goldshield’s management team, which includes Rakesh Patel, chief executive, and is working with HgCapital, the buy-out specialist, said it now holds an interest in just over 45 per cent of the company.
